Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data

Published:2011-11-30 Issue:3 Volume:55 Page:654-665
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

van Staa T. P.,Patel D.,Gallagher A. M.,de Bruin M. L.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-011-2390-3.pdf

Reference32 articles.

1. Hemkens LG, Grouven U, Bender R et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732–1744

2. Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjornsdottir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden. Diabetologia 52:1745–1754

3. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766–1777

4. Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765, Erratum 52: 2469

5. Smith U, Gale EAM (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52:1699–1708

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies;Prostate Cancer and Prostatic Diseases;2024-07-16

2. Does metformin really reduce prostate cancer risk: an up-to-date comprehensive genome-wide analysis;Diabetology & Metabolic Syndrome;2024-07-12

3. Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus;Cancer & Metabolism;2024-04-12

4. Mass Spectrometry Study about In Vitro and In Vivo Reaction between Metformin and Glucose: A Preliminary Investigation on Alternative Biological Behavior;International Journal of Molecular Sciences;2023-12-22

5. Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China;International Journal of Diabetes in Developing Countries;2023-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3